论文部分内容阅读
目的观察低分子肝素治疗不稳定型心绞痛疗效。方法选择诊断明确的不稳定型心绞痛患者88例,随机分为治疗组44例和对照组44例在以上治疗的基础上加用低分子肝素,观察两组对心绞痛的疗效。结果治疗组临床症状明显改善,心电图缺血ST段下移明显改善,且优于对照组。结论低分子肝素治疗不稳定型心绞痛疗效肯定,安全,优于常规抗心绞痛治疗。
Objective To observe the curative effect of low molecular weight heparin on unstable angina pectoris. Methods Eighty-eight patients with unstable angina pectoris were selected and randomly divided into treatment group (44 cases) and control group (44 cases). On the basis of the above treatment, low molecular weight heparin was used to observe the curative effect on angina pectoris in both groups. Results The clinical symptoms of the treatment group were significantly improved, ST-segment elevation of electrocardiographic ischemia was significantly improved, and better than the control group. Conclusion Low molecular weight heparin is effective and safe in the treatment of unstable angina pectoris, which is superior to the conventional anti-angina pectoris treatment.